Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

ConclusionsThe overall activity or number of NK cells may be a useful biomarker to predict immunotherapy response in patients with NSCLC.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research